We are live on ! Find out more
AP

AtonRa Partners Portfolio holdings

AUM $50.2M
1-Year Est. Return 47.76%
This Fund
S&P 500
This Quarter Est. Return
-10.66%
1 Year Est. Return
+47.76%
3 Year Est. Return
+48.32%
5 Year Est. Return
10 Year Est. Return
AUM
$47.7M
AUM Growth
-$16.9M
Cap. Flow
-$8.49M
Cap. Flow %
-17.82%
Top 10 Hldgs %
16.09%
Holding
128
New
12
Increased
4
Reduced
108
Closed
4

Top Buys

Rank Stock Value
1
TOST icon
Toast
TOST
+$437K
2
INTA icon
Intapp
INTA
+$434K
3
RELY icon
Remitly
RELY
+$420K
4
AXSM icon
Axsome Therapeutics
AXSM
+$387K
5
ANSS
Ansys
ANSS
+$262K

Top Sells

Rank Stock Value
1
PYPL icon
PayPal
PYPL
+$1.25M
2
LEGN icon
Legend Biotech
LEGN
+$491K
3
PLTR icon
Palantir
PLTR
+$406K
4
INTU icon
Intuit
INTU
+$387K
5
NVDA icon
NVIDIA
NVDA
+$379K

Sector Composition

Rank Sector Weight
1 Technology 52.33%
2 Healthcare 35.94%
3 Industrials 5.08%
4 Financials 4.01%
5 Communication Services 2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLTR icon
1
Palantir
PLTR
$318B
$937K 1.97%
58,574
-25,505
-30% -$406K
SWAV
2
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$871K 1.83%
4,374
-128
-3% -$30.3K
DXCM icon
3
DexCom
DXCM
$28.8B
$834K 1.75%
8,943
-212
-2% -$23.9K
SHOP icon
4
Shopify
SHOP
$160B
$785K 1.65%
14,384
-2,920
-17% -$177K
CRWD icon
5
CrowdStrike
CRWD
$195B
$771K 1.62%
18,428
+3,760
+26% +$146K
FOUR icon
6
Shift4
FOUR
$3.9B
$751K 1.57%
13,556
-2,302
-15% -$140K
EEFT icon
7
Euronet Worldwide
EEFT
$3.02B
$688K 1.44%
8,667
+305
+4% +$28.3K
SDGR icon
8
Schrodinger
SDGR
$1.13B
$682K 1.43%
24,122
-5,197
-18% -$209K
INSP icon
9
Inspire Medical Systems
INSP
$1.51B
$679K 1.42%
3,423
-130
-4% -$32.8K
TMDX icon
10
Transmedics
TMDX
$2.57B
$673K 1.41%
12,287
-179
-1% -$12.9K
EXAS
11
DELISTED
Exact Sciences
EXAS
$673K 1.41%
9,859
-256
-3% -$21.7K
LEGN icon
12
Legend Biotech
LEGN
$4.55B
$666K 1.4%
9,912
-7,070
-42% -$491K
INTU icon
13
Intuit
INTU
$79.3B
$657K 1.38%
1,285
-764
-37% -$387K
NBIX icon
14
Neurocrine Biosciences
NBIX
$18B
$626K 1.31%
5,562
-1,293
-19% -$136K
DSGX icon
15
Descartes Systems
DSGX
$6.08B
$624K 1.31%
8,502
-752
-8% -$56.7K
NVDA icon
16
NVIDIA
NVDA
$5.02T
$619K 1.3%
14,220
-8,460
-37% -$379K
XYZ
17
Block Inc
XYZ
$47.8B
$605K 1.27%
13,678
-2,391
-15% -$148K
PODD icon
18
Insulet
PODD
$11.3B
$592K 1.24%
3,712
-143
-4% -$32K
GWRE icon
19
Guidewire Software
GWRE
$11.9B
$590K 1.24%
6,561
-1,557
-19% -$130K
FSLR icon
20
First Solar
FSLR
$22.1B
$569K 1.19%
3,521
-386
-10% -$72K
MDGL icon
21
Madrigal Pharmaceuticals
MDGL
$12.6B
$563K 1.18%
3,857
-901
-19% -$170K
PACB icon
22
Pacific Biosciences
PACB
$435M
$543K 1.14%
65,082
+2,504
+4% +$28.6K
PRCT icon
23
Procept Biorobotics
PRCT
$1.05B
$540K 1.13%
16,462
-73
-0.4% -$2.49K
ALNY icon
24
Alnylam Pharmaceuticals
ALNY
$36.2B
$520K 1.09%
2,935
-675
-19% -$129K
TTEK icon
25
Tetra Tech
TTEK
$7.92B
$515K 1.08%
16,945
-1,605
-9% -$52.2K

Similar funds

AtonRa Partners's Q3 2023 Portfolio in Review

As of Q3 2023, AtonRa Partners held 128 positions worth $47.7M, down 26% from $64.6M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

AtonRa Partners withdrew a net $8.49M in Q3 2023, closing 4 positions and reducing 108 holdings. Its most notable exit was PayPal, an estimated $1.25M position sold in full.

By sector, the portfolio is most concentrated in Technology at 52% of assets, up from 48% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, AtonRa Partners opened a new position in Toast worth $377K.

  • AtonRa Partners's largest Q3 2023 buy was Toast: 20,116 shares worth $377K.
  • AtonRa Partners added most to CrowdStrike in Q3 2023, an estimated $146K increase.
  • AtonRa Partners's biggest Q3 2023 reduction was Legend Biotech, cutting an estimated $491K.
  • AtonRa Partners fully exited PayPal in Q3 2023, selling an estimated $1.25M.
  • AtonRa Partners's ten largest holdings make up 16% of its $47.7M portfolio in Q3 2023.
  • AtonRa Partners opened 12 new positions and closed 4 in Q3 2023.
  • AtonRa Partners's portfolio value fell 26% quarter-over-quarter to $47.7M.

Based on AtonRa Partners's 13F filing for Q3 2023, filed 25 Oct 2023.